About 600 Sero-discordant couples where one partner is HIV positive and the other is not will take part in a new research study to help decide the best HIV Treatment Strategy that will reduce the rate of infection in the population.
A study by the National Agency for Control of AIDS (NACA) is to help decide whether health workers choose to administer the anti-retroviral drug, Trvada- as a prevention or treatment for HIV/AIDS.
Multiple studies have established that anti-retroviral drugs could be used to reduce the rate of infection in a population in two different ways, known by the acronyms PrEP (Pre-Exposure Prophylis) and TasP (Treatment as Prevention).
Director General, National Agency for
Control of AIDS (NACA), Prof. John Idoko disclosed that the study is being carried out in Nigeria to see if it will work under normal conditions.
“The whole idea is to see if it will work so well in this situation, and if it does, it will become a policy. NACA understands that, given the data and experience to be gained from the project, it should be possible to present this to stakeholders for consideration as part of policy and guidelines for the comprehensive combination preventing program in the country.”
ThisDay News
Human Guinea-pigs.
ReplyDeleteWTF!!! Female teachers flee school after intimacy with mysterious baboon
Good to see Nigeria is catching up with the rest of the world! PEP has been used as prevention in most first world countries for years
DeleteVery interesting
ReplyDeletea.k.a EDWIN CHINEDU AZUBUKO said...
ReplyDelete.
Great news for people who like having unprotected sex....
.
.
***CURRENTLY IN JUPITER***
God please let this work. AMEN!!!
ReplyDeleteWaka pass
ReplyDeleteok
ReplyDeleteGood
ReplyDeleteOK oooo
ReplyDeleteAirtel why now, the network is just bad. Well done SDK am enjoying your conversation.
ReplyDeleteTrying tobopen the link again, may be I might be lucky.
we have heard.
ReplyDeleteGood news indeed
ReplyDeleteNext please...AL
ReplyDelete